NeuroRad TractsNeuroradiology education
Search→Residents→Fellowship→Explore Research↗Anatomy Lab↗Neuroradiology Oral Boards→
Brain

MR Spectroscopy: The Last Step in the Lesion Tree

Fellowship-level neuroradiology teaching by E. Brooke Schrickel, MD. Open this topic in the interactive reading room →

Watch · concise explainerWalk the lesion tree

Core clinical idea

No single advanced sequence calls an indeterminate brain lesion — walk a fixed multiparametric tree (enhancement -> diffusion -> perfusion -> spectroscopy) to separate high-grade glioma, metastasis, lymphoma, tumefactive demyelination, and abscess. The highest-stakes branch is the ring-enhancing lesion, where diffusion alone separates a drainable abscess from a tumor.

Bottom line

When conventional MR can't call it, walk enhancement -> diffusion -> perfusion -> spectroscopy — and on a ring-enhancing lesion, diffusion tells abscess from tumor.

Core workstation questions

  • Does it enhance, and is the ring complete or incomplete/open to the cortex?
  • Is diffusion restricted (abscess, lymphoma) or facilitated (tumefactive demyelination, glioma center)?
  • Is perfusion elevated (high-grade tumor) or decreased (demyelination, abscess, necrosis)?
  • Is choline elevated beyond the enhancing margin (infiltrative glioma) or sharply confined (metastasis)?
  • In a periventricular enhancing mass, is there low T2 and low ADC suggesting hypercellular lymphoma?
  • Is this multivoxel, with a contralateral normal-side reference voxel?
  • Are the spectra on a matched vertical scale, or is auto-scaling faking a tumor angle?
  • Is choline truly higher than the normal side, or is everything just depressed?

What changes reporting / management

  • A ring-enhancing lesion with central restricted diffusion (bright DWI/dark ADC) and low CBV is a pyogenic abscess until proven otherwise — say it, it routes the patient to drainage plus antibiotics rather than tumor surgery.
  • An incomplete ring open toward cortex with facilitated diffusion and low perfusion favors tumefactive demyelination over GBM — flag it before someone operates.
  • Sample the peritumoral non-enhancing region: elevated choline/abnormal perfusion there implies infiltrative glioma; a sharp drop-off implies a well-circumscribed metastasis.
  • Low T2 + low ADC in an enhancing periventricular mass should raise primary CNS lymphoma and prompt asking about steroid exposure before biopsy.
  • Read multivoxel, normalize the abnormal voxel to the same scale as a normal-side voxel before interpreting the Cho/NAA relationship.
  • Suggested phrasing: on scale-matched multivoxel spectroscopy, overall metabolite concentration is reduced relative to the contralateral normal voxel, favoring a non-tumoral low-metabolism process rather than neoplasm.
  • Require perfusion to agree — if choline suggests tumor but CBV is not elevated, distrust the tumor call and look for a non-neoplastic cause.
  • For tumefactive demyelination (open cortical ring, low perfusion, choline lower than true tumor), flag the off-ramp before the patient is framed for biopsy.

Practical traps

  • Tumefactive demyelinating lesions get biopsied or treated as GBM — the open ring plus low perfusion is the off-ramp.
  • Misreading a ring-enhancing abscess as a necrotic tumor by skipping the diffusion check.
  • Calling glioma vs metastasis off the enhancing core alone instead of interrogating the peritumoral zone.
  • Calling a subacute infarct (all metabolites down, choline below normal) a high-grade glioma because a single auto-scaled voxel shows a flipped Cho/NAA angle.
  • Reading the spectral angle instead of the scale-matched metabolite level.
  • Mistaking encephalitis (low choline, no CBV elevation) for tumor on conventional MR appearance.
  • Over-reading a normal infant developmental spectrum as pathology.

Teaching pearls

  • Ring-enhancing + central restricted diffusion + low CBV = abscess until proven otherwise.
  • An incomplete ring open to the cortex with low perfusion favors tumefactive demyelination, not GBM.
  • Choline beyond the enhancing edge means infiltrative glioma; a sharp peritumoral drop-off means metastasis.
  • Low T2 and low ADC in an enhancing periventricular mass — think lymphoma.
  • A single-voxel tumor angle proves nothing — scale-matched multivoxel comparison does.
  • Tumor = choline truly higher than normal; infarct/encephalitis = everything lower.
  • If choline says tumor but CBV is low, distrust the tumor call.
  • Tumefactive demyelination: open cortical ring, low perfusion, choline lower than true tumor — off-ramp before biopsy.
  • Low NAA/high choline can be a normal infant brain, not disease.

Source lectures

  • MR Spectroscopy in Neurodiagnosis, Part 2
  • MR Spectroscopy in Neurodiagnosis, Part 1

Educational material for radiology residents and neuroradiology fellows. Nothing here drives individual patient care, and it contains no patient data.